These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20923398)

  • 1. Solid lipid nanoparticles (SLNs) derived from para-acyl-calix[9]-arene: preparation and stability.
    Jebors S; Leydier A; Wu Q; Bertino Ghera B; Malbouyre M; Coleman AW
    J Microencapsul; 2010; 27(7):561-71. PubMed ID: 20923398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Para-acyl-calix-arene based solid lipid nanoparticles (SLNs): a detailed study of preparation and stability parameters.
    Shahgaldian P; Da Silva E; Coleman AW; Rather B; Zaworotko MJ
    Int J Pharm; 2003 Mar; 253(1-2):23-38. PubMed ID: 12593934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation of ion pairing as an alternative to improve encapsulation and stability and to reduce skin irritation of retinoic acid loaded in solid lipid nanoparticles.
    Castro GA; Coelho AL; Oliveira CA; Mahecha GA; Oréfice RL; Ferreira LA
    Int J Pharm; 2009 Oct; 381(1):77-83. PubMed ID: 19647057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solvent injection-lyophilization of tert-butyl alcohol/water cosolvent systems for the preparation of drug-loaded solid lipid nanoparticles.
    Wang T; Wang N; Zhang Y; Shen W; Gao X; Li T
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):254-61. PubMed ID: 20447810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimization of the lyophilization process for long-term stability of solid-lipid nanoparticles.
    Howard MD; Lu X; Jay M; Dziubla TD
    Drug Dev Ind Pharm; 2012 Oct; 38(10):1270-9. PubMed ID: 22235767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization and formulation optimization of solid lipid nanoparticles in vitamin K1 delivery.
    Liu CH; Wu CT; Fang JY
    Drug Dev Ind Pharm; 2010 Jul; 36(7):751-61. PubMed ID: 20136495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and in vitro, in vivo evaluations of norfloxacin-loaded solid lipid nanopartices for oral delivery.
    Dong Z; Xie S; Zhu L; Wang Y; Wang X; Zhou W
    Drug Deliv; 2011 Aug; 18(6):441-50. PubMed ID: 21554156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fine tuning the production of nanosized beta-carotene particles using spinning disk processing.
    Anantachoke N; Makha M; Raston CL; Reutrakul V; Smith NC; Saunders M
    J Am Chem Soc; 2006 Oct; 128(42):13847-53. PubMed ID: 17044713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid.
    Attama AA; Müller-Goymann CC
    Int J Pharm; 2007 Apr; 334(1-2):179-89. PubMed ID: 17140752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancement of oral bioavailability of pentoxifylline by solid lipid nanoparticles.
    Varshosaz J; Minayian M; Moazen E
    J Liposome Res; 2010 Jun; 20(2):115-23. PubMed ID: 19694503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid lipid nanoparticles prepared by solvent diffusion method in a nanoreactor system.
    Yuan H; Huang LF; Du YZ; Ying XY; You J; Hu FQ; Zeng S
    Colloids Surf B Biointerfaces; 2008 Feb; 61(2):132-7. PubMed ID: 17888636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation.
    Dudhipala N; Janga KY
    Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid.
    Vighi E; Ruozi B; Montanari M; Battini R; Leo E
    Eur J Pharm Biopharm; 2007 Sep; 67(2):320-8. PubMed ID: 17368876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid lipid nanoparticles for ocular drug delivery.
    Seyfoddin A; Shaw J; Al-Kassas R
    Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN).
    Helgason T; Awad TS; Kristbergsson K; McClements DJ; Weiss J
    J Colloid Interface Sci; 2009 Jun; 334(1):75-81. PubMed ID: 19380149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production & stability of stavudine solid lipid nanoparticles--from lab to industrial scale.
    Shegokar R; Singh KK; Müller RH
    Int J Pharm; 2011 Sep; 416(2):461-70. PubMed ID: 20727389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of lipid excipients in solid lipid nanoparticles.
    Radomska-Soukharev A
    Adv Drug Deliv Rev; 2007 Jul; 59(6):411-8. PubMed ID: 17553589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid lipid nanoparticles formed by solvent-in-water emulsion-diffusion technique: development and influence on insulin stability.
    Battaglia L; Trotta M; Gallarate M; Carlotti ME; Zara GP; Bargoni A
    J Microencapsul; 2007 Nov; 24(7):660-72. PubMed ID: 17763060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization.
    Attama AA; Schicke BC; Paepenmüller T; Müller-Goymann CC
    Eur J Pharm Biopharm; 2007 Aug; 67(1):48-57. PubMed ID: 17276663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid lipid nanoparticles for encapsulation of hydrophilic drugs by an organic solvent free double emulsion technique.
    Becker Peres L; Becker Peres L; de Araújo PHH; Sayer C
    Colloids Surf B Biointerfaces; 2016 Apr; 140():317-323. PubMed ID: 26764112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.